Kimberly-Clark Corp. will acquire Tylenol maker Kenvue Inc. in a cash and stock deal valued at almost $49 billion the two ...

The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to autism.

An AI collaboration boosted the company behind the largest U.S. cloud service on Monday, Nov. 3, 2025, while shares of the ...

The combined company will have a large stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and ...